文献速递介入腹部外周血管USDSA

超声引导门静脉穿刺与经皮门静脉导丝置入可缩短TIPS术中操作时间并降低辐射剂量

Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement.
PubMed 文献 · AJR Am J Roentgenol · 2020-07-29

回顾2005至2019年264例TIPS患者,按门静脉穿刺技术分为超声引导组、透视楔入肝静脉造影组和经皮超声引导门静脉导丝置入组;经皮导丝置入组麻醉时间与透视时间更短,超声引导组对比剂用量和穿刺次数少于透视造影组,超声引导与经皮导丝置入两组合并后并发症少于透视造影组。

要点

  • 经皮超声引导门静脉导丝置入组麻醉时间162.6±39.7分钟,短于超声引导组190.2±45.6分钟和透视造影组199.7±59.5分钟。
  • 透视造影组透视时间38.9±20.8分钟,长于经皮导丝置入组29.5±14.6分钟,差异有统计学意义。
  • 超声引导组穿刺次数中位2次,少于透视造影组中位4次;超声引导组对比剂67.9±36.8 mL,少于透视造影组87.1±42.9 mL。

核心结论

  • TIPS术中超声引导门静脉穿刺和经皮门静脉导丝置入辅助透视定位与更短的操作时间和透视时间相关,并可能减少并发症。

研究设计与样本

  • 回顾性分析2005至2019年接受TIPS创建的264例患者病历,按门静脉穿刺技术分为三组:组1经腹超声引导门静脉穿刺54例(20.5%),组2透视引导楔入肝静脉造影172例(65.1%),组3经皮超声引导门静脉导丝置入辅助透视定位38例(14.4%)。

诊断标准与关键数值

  • 组1平均透视时间34.8±16.6分钟,与组2的38.9±20.8分钟无差异(p=.09),与组3的29.5±14.6分钟无差异(p=.06);组2透视时间显著长于组3(p=.005)。
  • 组1平均总麻醉时间190.2±45.6分钟,与组2的199.7±59.5分钟无差异(p=.15);组3平均麻醉时间162.6±39.7分钟,显著短于组1(p=.003)和组2(p<.001)。
  • 组1平均对比剂用量67.9±36.8 mL,显著低于组2的87.1±42.9 mL(p=.005)。
  • 组2肝内穿刺次数中位4次(IQR 1-7次),多于组1中位2次(IQR 1-4次;p=.004)和组3中位2次(IQR 1-7.25次;p=.04)。
  • 组1与组3并发症合并后,显著少于组2(p=.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. TIPS placement is an effective method for treating a number of complications of portal hypertension. Although this complex procedure has been firmly established in treatment algorithms, more data are needed to determine the most efficient and safest ways to perform the procedure. OBJECTIVE. The purpose of this study was to determine the effect of three different techniques of portal vein (PV) cannulation during TIPS placement on procedure efficiency. METHODS. The medical records of patients who underwent TIPS creation between 2005 and 2019 were reviewed. On the basis of the PV access technique used, patients were grouped as follows: group 1 (G1) included patients who underwent a transabdominal ultrasound (US)-guided technique to obtain PV access, group 2 (G2) consisted of those who underwent fluoroscopically guided wedged hepatic portography, and group 3 (G3) included those who underwent percutaneous US-guided PV guidewire placement for fluoroscopic targeting. RESULTS. Of the 264 patients who underwent TIPS creation, 54 (20.5%) were in G1, 172 (65.1%) were in G2, and 38 (14.4%) were in G3. The mean (± SD) fluoroscopic time in G1 (34.8 ± 16.6 minutes) did not differ from that in either G2 (38.9 ± 20.8 minutes; p = .09) or G3 (29.5 ± 14.6 minutes; p = .06). However, G2 patients had significantly longer fluoroscopic times than G3 patients (p = .005). The mean total anesthesia time in G1 (190.2 ± 45.6 minutes) did not differ from that in G2 (199.7 ± 59.5 minutes; p = .15). However, G3 had a mean anesthesia time (162.6 ± 39.7 minutes) that was significantly shorter than that in both G1 (p = .003) and G2 (p < .001). The mean contrast volume was significantly lower in G1 than in G2 (67.9 ± 36.8 mL vs 87.1 ± 42.9 mL; p = .005). More intrahepatic needle passes were required in G2 (median, 4 passes; interquartile range [IQR], 1-7 passes) than in G1 (median, 2 passes; IQR, 1-4 passes; p = .004) and G3 (median, 2 passes; IQR, 1-7.25 passes; p = .04). When complications in G1 and G3 were pooled, this cohort had significantly fewer complications than G2 (p = .01). CONCLUSION. Ultrasound-guided PV access and percutaneous PV guidewire placement for fluoroscopic targeting during TIPS creation are associated with shorter procedure and fluoroscopic times and potentially decreased complications. CLINICAL IMPACT. The present study helps interventional radiologists understand the safest and most efficient way to access the PV, which is a key step during TIPS placement.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Cam I, Gencturk M, Shrestha P, et al. Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement. AJR Am J Roentgenol. 2020. PMID: 32755214. doi:10.2214/AJR.20.23846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。